Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

In NASH Race, Bad News For Conatus, Good News For Genfit In PBC

Mon, 12/10/2018 - 12:37pm

Conatus’ emricasan fails to meet the primary endpoint for portal hypertension in NASH patients with cirrhosis, but firm stresses promising...

      Related Stories 

Cross-Country Collaborations, Business As Usual?

Mon, 12/10/2018 - 8:12am

Pharmaceutical companies cannot afford to ignore the growing number of cross-country collaborations springing up in Europe aimed at securing more...

      Related Stories 

All Downhill: Ranbaxy Singh Brothers Trade Charges, Blows

Fri, 12/07/2018 - 4:36am

The Singh brothers' feud has moved from a war of words allegedly to blows, with any efforts at reconciliation looking...

      Related Stories 

Bayer Still Confident Of Future Prospects Post-Xarelto

Fri, 12/07/2018 - 4:24am

The German group has been talking up its pharmaceuticals division but analysts are not convinced it has addressed the elephant...

      Related Stories 

Brexit And Cooperation: Insights From Danish Medicines Agency Head Thomas Senderovitz

Fri, 12/07/2018 - 4:08am

It was inevitable that Brexit would be the key theme of an interview with Danish Medicines Agency head Thomas Senderovitz...

      Related Stories 

Cell And Gene Therapy Logistics Requires Early Planning

Fri, 12/07/2018 - 1:16am

It has become standard practice for manufacturing to get early attention in the cell and gene therapy development, but logistics...

      Related Stories 

Humira Biosimilars Face Complex Asia Outlook As Launches Edge Closer

Fri, 12/07/2018 - 1:05am

The Asia Pacific region presents large potential opportunities for the development of biosimilar versions of big-selling original biologics as these...

      Related Stories 

Deal Watch: Boehringer Teams Up In CNS Disorders Again, This Time With Domain

Thu, 12/06/2018 - 12:51pm

Following last December’s partnership in CNS with Autifony, BI undertakes a screening collaboration with Domain. Leo maintains its busy deal-making...

      Related Stories 

Mallinckrodt Creating Two Companies: Generics And Innovative Specialty Drugs

Thu, 12/06/2018 - 11:47am

The company, which makes generic opioid products and the controversial Acthar Gel, is looking to chart a new course for...

      Related Stories 

AbbVie's Rova-T Disappoints As Second-Line SCLC Trial Halted

Thu, 12/06/2018 - 6:46am

Enrolment In the Phase III TAHOE study has been halted due to shorter overall survival in the Rova-T arm compared...

      Related Stories 

Pharma: Be Prepared For Tougher Price Negotiations For IO Combos And Expansions In Europe

Thu, 12/06/2018 - 6:26am

Payers are increasingly likely to implement new strategies to manage price negotiations for immuno-oncology combinations, as competition  heats up among...

      Related Stories 

Pages